{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:54:54Z","timestamp":1782320094602,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.vaccine.2004.01.041","type":"journal-article","created":{"date-parts":[[2004,2,17]],"date-time":"2004-02-17T10:08:37Z","timestamp":1077012517000},"page":"2743-2749","source":"Crossref","is-referenced-by-count":63,"title":["Persistence of protective immunity following vaccination against tick-borne encephalitis\u2014longer than expected?"],"prefix":"10.1016","volume":"22","author":[{"given":"P","family":"Rendi-Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Zent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Jaehnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mikolasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.01.041_BIB1","first-page":"350","article-title":"\u00dcber epidemische akute Menigitis serosa","volume":"44","author":"Schneider","year":"1931","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB2","first-page":"255","article-title":"Spring-summer tick-borne encephalitis (Russian)","volume":"56","author":"Zilber","year":"1939","journal-title":"Arkhiv Biol Nauk"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB3","unstructured":"Monath TP, Heinz FX, Flaviviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 961\u20131034."},{"key":"10.1016\/j.vaccine.2004.01.041_BIB4","unstructured":"Dittmann S, Jilg W, Tick-borne encephalitis in the European region. Copenhagen (Denmark): WHO Regional Office for Europe; 1998."},{"key":"10.1016\/j.vaccine.2004.01.041_BIB5","doi-asserted-by":"crossref","unstructured":"Kunz C. Epidemiology of tick-borne encephalitis and the impact of vaccination on the incidence of disease. In: Eible MM, Huber C, Peter HH, Wahn V, editors. Proceedings of the Fifth Symposium on Immunology. Berlin: Springer; 1996. p. 143\u20139.","DOI":"10.1007\/978-3-642-79896-2_13"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB6","doi-asserted-by":"crossref","first-page":"S1\/41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21","author":"Barret","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","article-title":"Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adulescents and adults","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB8","first-page":"273","article-title":"Die FSME-Impfung, eine Ma\u03b2nahme der Vorsorgemedizin mit hoher Akzeptanz in \u00d6sterreich","volume":"12","author":"Kunz","year":"1991","journal-title":"Wiener Med Woschr"},{"issue":"1","key":"10.1016\/j.vaccine.2004.01.041_BIB9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0264-410X(91)90315-W","article-title":"Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization","volume":"9","author":"Klockmann","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB10","doi-asserted-by":"crossref","unstructured":"Zent O, Banzhoff A, Hilbert AK, Meriste S, S\u0142uzewski W, Wittermann CH, Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 2003, in press.","DOI":"10.1016\/S0264-410X(03)00421-3"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s150100050051","article-title":"Laboratory findings in tick-borne encephalitis\u2014correlation with clinical outcome","volume":"28","author":"Kaiser","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA; hemagglutination inhibition, and neutralization test after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J Med Virol"},{"issue":"Suppl.1","key":"10.1016\/j.vaccine.2004.01.041_BIB13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(02)00819-8","article-title":"Diagnosis of tick-borne encephalitis","volume":"21","author":"Holzmann","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0264-410X(00)00410-2","article-title":"Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience","volume":"19","author":"Rendi-Wagner","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of non-response to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N Engl J Med"},{"issue":"Suppl. 3A","key":"10.1016\/j.vaccine.2004.01.041_BIB16","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0002-9343(89)90530-5","article-title":"Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations","volume":"87","author":"Hollinger","year":"1989","journal-title":"Am J Med"},{"issue":"16","key":"10.1016\/j.vaccine.2004.01.041_BIB17","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0264-410X(99)00503-4","article-title":"Costimulatory mechanisms in the elderly","volume":"18","author":"Effros","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-065X.1997.tb01037.x","article-title":"Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease","volume":"160","author":"Wick","year":"1997","journal-title":"Immun Rev"},{"issue":"16","key":"10.1016\/j.vaccine.2004.01.041_BIB19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S0264-410X(99)00504-6","article-title":"In vitro senescence models for human T lymphocytes","volume":"18","author":"Pawelec","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2004.01.041_BIB20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jmv.1890440425","article-title":"Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence","volume":"44","author":"Van Damme","year":"1994","journal-title":"J Med Virol"},{"issue":"Suppl.1","key":"10.1016\/j.vaccine.2004.01.041_BIB21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0264-410X(92)90566-3","article-title":"Persistance of vaccine-induced antibody to hepatitis A virus","volume":"10","author":"Wiedermann","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB22","doi-asserted-by":"crossref","unstructured":"Kunz C, Erfahrungen mit einem modernen Impfstoff am Beispiel der FSME-Impfung in \u00d6sterreich. In: Stickl HA, Kunz C, editor. Moderne impfungen. Berlin: Springer; 1989. p. 15\u201325.","DOI":"10.1007\/978-3-642-75055-7_2"},{"key":"10.1016\/j.vaccine.2004.01.041_BIB23","doi-asserted-by":"crossref","first-page":"S1\/50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T02:50:23Z","timestamp":1550199023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":23,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0264410X04001112"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}